Safety of Pegfilgrastim in Children

Abstract

Get full access to this article

View all access options for this article.

References

Snyder

, Stringham

. Pegfilgrastim-induced hyper-leukocytosis. Ann Pharmacother2007;41:1524–30. Epub 31 Jul 2007. DOI 10.1345/aph.lK093

André

, Kababri

, Bertrand

, . Safety and efficacy of pegfilgrastim in children with cancer receiving myelosuppressive chemotherapy. Anticancer Drugs2007;18:277–81.

Poele EM

, Kamps

, Tamminga

, Leeuw

, Postma

, de

Bont ES.

Pegfilgrastim in pediatric cancer patients. J Pediatric Hematol Oncol2005;27:627–9.

Wendelin

, Lackner

, Schwinger

, Sovinz

Urban

Once-per-cycle pegfilgrastim versus daily filgrastim in pediatric patients with Ewing sarcoma. J Pediatr Hematol Oncol2005;27:449–51.

Smith

, Khatcheressian

, Lyman

, . 2006 Update of recommendations for the use of white blood cell growth factors: an evidence-based, clinical practice guideline. J Clin Oncol2006;19:3187–205.